Application
Western blot analysis of CCR3 Antibody (Center) in Jurkat cell line lysates (35ug/lane). CCR3 (arrow) was detected using the purified Pab.Application
CCR3 Antibody (Center) flow cytometry analysis of Jurkat cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CCR3 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CMKBR3 |
|---|---|
| Alternative Names | CCR3 CMKBR3 C-C chemokine receptor type 3 Eosinophil eotaxin receptor CD_antigen=CD193 |
| Molecular Weight(MW) | 41044 Da |
| Function | Receptor for a C-C type chemokine. Binds to eotaxin, eotaxin-3, MCP-3, MCP-4, RANTES and MIP-1 delta. Subsequently transduces a signal by increasing the intracellular calcium ions level. Alternative coreceptor with CD4 for HIV-1 infection |
| Tissue Specificity | In eosinophils as well as trace amounts in neutrophils and monocytes |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 1232 |
|---|
Application
Western blot analysis of CCR3 Antibody (Center) in Jurkat cell line lysates (35ug/lane). CCR3 (arrow) was detected using the purified Pab.
Application
CCR3 Antibody (Center) flow cytometry analysis of Jurkat cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
